Ziprasidone vs Standard Therapy for Agitated Patients in the ED
| Status: | Withdrawn |
|---|---|
| Conditions: | Neurology, Psychiatric, Psychiatric, Psychiatric |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 100 |
| Updated: | 9/27/2017 |
| Start Date: | September 2008 |
| End Date: | July 2011 |
Prospective Double Blind Randomized Trial of Intramuscular Ziprasidone Compared With Standard Antipsychotic Therapy For The Treatment Of The Acutely Agitated Patient In The Emergency Department
The primary objective is to determine if ziprasidone is superior to standard therapies in the
emergency department treatment of the acutely agitated patient. The primary outcome will be
the length of time taken until the patient is ready to be evaluated by the psychiatric
service, or until a disposition is made.
emergency department treatment of the acutely agitated patient. The primary outcome will be
the length of time taken until the patient is ready to be evaluated by the psychiatric
service, or until a disposition is made.
Inclusion Criteria:
- Acutely agitated
- Requires chemical sedation
Exclusion Criteria:
- Physician preference for a specific chemical sedative
- Known allergy to any study medications
We found this trial at
1
site
900 23rd Street Northwest
Washington, D.C., District of Columbia 20037
Washington, D.C., District of Columbia 20037
Click here to add this to my saved trials
